Medical Literature Monitoring Services
Medical Literature Monitoring Services
Medical literature monitoring (MLM) is a cornerstone of modern pharmacovigilance programs. Regulatory agencies such as the FDA and EMA mandate systematic review of global scientific and medical literature to identify potential safety signals related to medicinal products. Med Comm offers comprehensive medical literature monitoring services that help pharmaceutical companies maintain compliance with international pharmacovigilance regulations. This ongoing surveillance plays a critical role in maintaining an accurate and current safety profile for products while ensuring compliance with international pharmacovigilance regulations.
Beyond Keyword Searches: A Strategic and Intelligent Approach
Effective literature surveillance is far more than keyword-based querying. It demands a structured and intelligent process—one that not only identifies and evaluates potential adverse drug reactions in peer-reviewed journals and conference abstracts but also integrates findings seamlessly into regulatory reporting workflows. Our approach ensures early signal detection and enhances safety surveillance capabilities that go beyond spontaneous reporting systems.
Our AI-Enhanced Literature Monitoring Services
At Med Communications, we provide comprehensive, scalable medical literature monitoring services tailored to your unique pharmacovigilance needs. Leveraging AI and automation through platforms like DistillerSR, and utilizing trusted databases, our expert team streamlines literature reviews with precision, consistency, and regulatory compliance.
Our services include:
- Development and validation of product-specific, regulatory-compliant search strategies
- Automated and manual screening of global scientific literature and conference proceedings
- AI-supported deduplication, prioritization, and data extraction
- Expert review and medical assessment of relevant publications
- Preparation of individual case safety reports (ICSRs) for regulatory submission
- Literature integration into Periodic Safety Update Reports (PSURs) and Development Safety Update Reports (DSURs)
- Ongoing optimization of search parameters to improve efficiency and reduce false positives
Why Choose Med Communications?
Our literature surveillance workflows combine human expertise with advanced automation tools, offering a highly efficient, transparent, and audit-ready process. With built-in quality control checks and continuous monitoring of evolving regulatory guidelines, we ensure our clients remain compliant across all jurisdictions.
Whether you’re monitoring a single product or a global portfolio, our adaptable services are designed to meet your operational, budgetary, and regulatory requirements.
Partner with Med Communications to enhance your pharmacovigilance strategy through robust, AI-augmented literature monitoring. Contact us today to explore how we can support your safety surveillance needs.